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SUMMARY.-Dibutylnitrosamine has been administered continuously in the
drinking water to two groups of C57BL/6 mice. The first group (50 males, 50
females) received 30 mg./kg./day and the second (50 males, 50 females) 7*6 mg./
kg./day. Ofmicereaching autopsy squamous cell carcinoma ofthebladder was
found in44/90 at the high dose and 19/89 atthe low dose. Bladder tumours were
found predominantly in males, the ratio of tumours in males and females being
4.4: 1 and 8-5: 1 at the high and low dose levels, respectively. Carcinomas and
papillomas of the oesophagus were found in all but 2 of the females and all but
6 of the males. In addition 5 carcinomas of the fore-stomach in the low dose
group and a total in both groups of 13 tumours of the soft palate and tongue
were found. The mean cumulative doses and respective induction times for
the high and low dose groups were 7*4 and 2-0 g./kg., and 240 and 260 days.
N-NITROSO compounds were first shown to be carcinogenic by Magee and
Barnes (1956) and have since been the subject of extensive research to determine
both their mode of action and their structure-activity relationship. The review
by Magee and Barnes (1967) gives a comprehensive coverage of this topic. The
dialkylnitrosamines predominantlyproducetumours oftheliver, lung, oesophagus,
kidney, stomach, nasal sinus and bronchus. Dibutylnitrosamine (DBN) and its
hydroxylated derivative butyl-4-hydroxybutylnitrosamine are unique among the
nitrosamines in their capacity to induce bladder tumours in the rat (Druckrey
et al., 1962, 1964). This paper describes the carcinogenic action of DBN ad-
ministered at two dose levels to C57BL/6 mice.
MATERIALS AND METHODS
Inbred C57BL/6 mice with a low spontaneous tumour incidence (Green, 1968)
were housed in groups of 10 and allowed unlimited access to food (Thomson Diet,
Ley et al., 1969) and drinking water containing the carcinogen. Treatment was
commenced when 10-12 weeks old. The purity ofthe DBN used (obtained from
Eastman-Kodak) was checked by thin-layer and gas liquid chromatography.
Drinking water solutions were changed twice weekly and the volume drunk
recorded. The total carcinogenic dose for each mouse was calculated on the
assumption that individual mice within a cage consumed similar amounts ofwater
(Clapp and Craig, 1967).
Mice were divided into two dose groups, Group A (50 males, 50 females)
receiving 240 mg./litre ofDBN and Group B (50 males, 50 females) 60mg./litre of
DBN. When after 197 days the majority of Group A males were grossly hae-
maturic the carcinogen solution was replaced by drinking water for approximatelyDIBUTYLNITROSAMINE BLADDER TUMOURS IN MICE 353
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half the males and females of this group. In the remainder of this group and all
of Group B treatment was continued until animals became moribund or died.
Whenever possible a complete autopsy was performed. Tissues were fixed with
10% formalin and stained with haematoxylin and eosin for histological examina-
tion. Bladders were distended with 10% formalin by urethral cannulation before
removal (Sen Gupta, 1962). After fixation the base and apex were severedto allow
examination of the mucosa for tumours.
RESULTS
Tumours were found in all mice reaching autopsy. A total of 10 animals in
Group A (5 males, 5 females) and 11 animals in Group B (3 males, 8 females) were
extensively cannibalized when found. Their deaths occurred at a time when
lethal tumours were occurring and have been excluded from the data.
Group A. The mean dosage was 29*1 mg./kg./day and 30'9 mg./kg./day for
the males and females respectively; details of tumour incidence are given in
Table I. Bladder tumours developed in 44 animals (48%) the distribution
showing a marked sex variation with 80% ofthe males andonly 18% ofthefemales
developing tumours of this organ, a ratio of 4.4: 1. The bladders of all 9 males
with oesophageal tumours as sole site showed varying degrees ofhyperplasia while
many ofthe bladders ofequivalent females were apparently normal. Oesophageal
tumours developed in all but 5 ofthe mice. All 5 tongue and soft palate tumours
were found in conjunction with oesophageal tumours and in 2 cases, were also
associated with bladder tumours.
The mean tumour induction time (all sites) for the males (236 ± 25-4 days) did
not differsignificantly fromthat ofthefemales (243 A 24-2 days), however, bladder
tumours developed in females significantly later (P > 0-01) than in males (Table
II). It may be speculated that had not death from oesophageal tumours super-
vened both sexes would have had a uniformly high bladder tumour incidence.
TABLE II.-Tumour Induction Timefor Group A and B Classifiedfor Sex and
Tumour Site
Tumour site and induction time (days)~~~~~~~~A
Group(a) Sex Number All sites Bladder Oesophagus(b)
A1 Male . 20 236±20(c) 234±22 241±10
A2 Male 25 . 237±29 234±31 251±7
A1 . Female 21 . 243±22 253±13 240±23
A2 Female . 24 . 245±26 253±17 243±28
B . Male . 47 . 261±31b8 268±29 259±33
Female . 42 . 256±31-3 232(d) 256±30
(a) A1 treatment ceased after 197 days, A2 treatment continued until death.
(b) All cases except when in conjunction with bladder.
(c) Mean ± standard deviation.
(d) Two mice only.
The tumour incidence and latency in those animals in which treatment was ceased
after 197 days did not differ significantly from those in which treatment was
continued until death (Table II). The mean total carcinogenic dose for this latter
group was 6310 ± 581 mg./kg. and 7115 + 710 mg./kg. in the males and females
respectively. For all other purposes Group A has been dealt with as a whole.
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Group B. The mean dose consumed was 7*6 mg./kg./day and 8'2 mg./kg./day
for the males and females leading to a respective total carcinogenic dose of
1986 ± 199 mg./kg. and 2096 ± 236 mg./kg. Details of tumour induction are
given in Table I. Bladder tumours developed in only 19 animals of this group,
a sex ratio of 8-5: 1 in favour of the males being even more pronounced than in
Group A. Except for 3 mice that died early with tumours ofthe fore-stomach, all
animals developed oesophageal tumours. In a total of 5 mice carcinoma of the
fore-stomach was recorded; a tumour site not observed in Group A. No signi-
ficant differences in induction times could be observed between the various tumour
sites or between male and female mice (Table II).
Pathology
Tumours were detected in all animals reaching autopsy. Oesophageal tumours
were always multifocal and bladder tumours generally multifocal in origin.
Several organs were often involved in the same animal. As far as can be judged
no deaths occurred as a result of non-specific or hepato-cellular toxicity. Death
most frequently resulted from respiratory obstruction ofthe glottal region caused
by malignant or hyperplastic growth of the squamous epithelium in this region.
Even large tumours ofthe oesophagus were rarely found to cause death, the glottis
with its cartilaginous structure presumably is less able to accommodateobstructive
masses. In males with the bladder as sole tumour site hydronephrosis clearly
indicated renal failure as the cause of death. Similarly in those mice developing
tumours of the fore-stomach, oesophageal reflux and absence of food in the
alimentary tract indicated death from starvation.
Haematuria was first observedina male from Group A after 132 days treatment
and after 233 days 38 mice in Group A had shown this symptom. As mice were
not consistently haematuric it seems probable that all bladder tumours were
preceded by haematuria, the time interval generally elapsing between onset of
symptoms and death being approximately 40 days.
Bladder tumours were frequently multifocal in origin. Squamous cell
carcinoma were found in all affected bladders sometimes in association with
papillomas. None ofthe carcinomas had penetrated further than the muscle wall
of the bladder but many were infiltrating under adjacent epithelium and into the
bladder lumen (Fig. 1). No prediliction for a particular site within the bladder
could be determined as has been shown for 2-acetylaminofluorene in the rabbit
(Wood, 1968). In cases where the carcinoma had not yet spread to involve the
entire epithelium, microscopic examination revealed the epithelium to be in parts
essentially normal (2-3 cells deep), progressing to hyperplastic (7-10 cells deep)
often with oedema of the underlying connective tissue. Sometimes associated
with this hyperplastic epithelium were found pedunculated papillomas (Fig. 2).
Subcutaneous implants into normal male mice of portions of bladder carcinoma
grew slowly to produce large tumours with necrotic centres.
Tumours of the oesophagus were invariably of multifocal origin and for
reasons of simplicity the pharynx has been included in this classification. On
autopsy the tumours were readily observed giving the oesophagus theappearance
of a string of beads. These nodules were generally found to be due to large
papillomas having a cauliflower-like morphology and a slender base. It was not
uncommon to find up to 12 papillomas ofvarious sizes within a single oesophagus.
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Papillomas occurring in the oral cavity had a similar morphology. Squamous cell
carcinomas, with the exception of 3 cases, were 1 mm. or less in diameter and it is
reasonable to assume that they did not contribute to the death of the animals
(Fig. 3). The hyperplasia of the squamous epithelium of the pharynx which led
to the death of the majority of the experimental animals can clearly be seen in
Fig. 4 which also demonstrates the abnormal state of the oesophageal epithelium
contrasting strongly with the apparently normal trachea. The distribution of
tumours down the length of the oesophagus appeared to be random. Although
oesophageal tumours were found to occur in close proximity to the gastro-oeso-
phageal junction, in only 5 cases were tumours found in the stomach. These were
squamous cell carcinoma of the fore-stomach and were all large and apparently
highly malignant. Metastases to the diaphragm and intestinal mesentery were
found in 2 cases. Metastases of other tumours were not observed. Mice with
bladder carcinomas generally had enlarged abdominal lymph nodes but tumour
cells were not detected when they were examined histologically.
In spite of the centrolobular necrosis ofthe liver produced after toxic doses of
DBN in rats (Heath, 1962) and mice (these laboratories, unpublished results) no
pathological changes could be detected in the livers of mice treated with the dose
levels reported here. In addition, despite the intimate contact of urine with -the
entire urinary tract, neither kidneys nor ureters were affected (neglecting hydro-
nephrosis consequent on bladder tumour development).
DISCUSSION
Variations in species, dose and mode of administration led to very significant
changes in the carcinogenic action ofDBN (Table III). Liver tumours have been
reported in the rat (Druckrey et al., 1962, 1964), guinea pig (Ivankovic and
Bucheler, 1968) and ICR mouse (Takayama and Imaizumi, 1969) but were not
observed inthe present experiments. Conversely bladder tumours were not found
in the male ICR mouse but occur with high frequency in the male C57BL/6
mouse; a strain with a very low spontaneous tumour incidence. The difference
between these two mouse strains may simply be related to the dose levels used.
In our experiments using the C57BL/6 mouse the male bladder tumour incidence
falls from 80% in animals given 30 mg./kg./day to 36% at 7-5 mg./kg./day, as the
dosage to the ICR mouse was only 5-24mg./kg./day (Takayama, 1969, personal
communication), this may have been below the threshold for bladder tumour
induction. The mechanism by which the bladder is spared could be analogous to
the situation in rats treated with dimethylnitrosamine which, although pre-
dominantly a liver carcinogen, induces kidney tumours when given in acute near
toxic doses, probably by overriding the ability of the liver to metabolize the
EXPLANATION OF PLATES
FIG. 1.-Edge of squamous cell carcinoma ofbladder showing invasion ofmuscle and adjacent
epithelium.
FiG. 2.-Bladder papilloma showing no invasive tendencies.
FIG. 3.-Squamous cell carcinoma of the oesophagus. The tumour (T) projects into and has
practically blocked the lumen. Areas of invasion in the smooth muscle layer are arrowed.
FIG. 4.-Section through the glottal region (G) showing the occluded airway (arrowed). The
normal state ofthe tracheal epithelium (Tr) contrasts stronglywith thatof the oesophagus (0)
which shows hyperplasia and probable early neoplastic change.
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carcinogen and allowing a greater quantity to reach the kidneys (Magee and
Barnes, 1962; Swann and McLean, 1969). The only other published reference to
the action ofDBN in the mouse is a limited study ofthe short term administration
to C57 x IF mice at a dose level of 1 mg./mouse/day (approximately 30 mg./kg./
day) which induced hyperplasia ofthe bladder epithelium. This finding was part
of a study correlating early hyperplasia with carcinogenic potential (Clayson et al.,
1965).
Many systemically active carcinogens such as fl-naphthylamine (Boyland,
1963), 2-acetylaminofluorene (Miller et al., 1961a) and 4-acetylaminobiphenyl
(Miller et al., 1961b) are activated by metabolic N-hydroxylation, these inter-
mediates fulfilling therequirements for aproximal carcinogen. WhileN-hydroxyl-
ation could occur with DBN to produce a reactive hydroxylamine derivative
(Heath, 1962) it is more likely that C-hydroxylation occurs, possibly followed by
conjugation, to produce a hydrophilic compound which is not reabsorbed by the
renal tubules and which could yield a reactive intermediate, either spontaneously
or enzymatically, in the bladder. Druckrey et al. (1964) favour this as the most
probable sequence of events leading to the excretion of a urinary carcinogen, and
have demonstrated in the urine of treated rats the presence of several polar
metabolites of DBN in which the nitroso group is intact. Although these meta-
bolites have not been identified they have shown that butyl-4-hydroxybutyl-
nitrosamine is a potent carcinogen acting solely on the bladder (Druckrey et al.,
1964).
The exact nature of the reactive intermediate in nitrosamine carcinogenesis is
currently the subject ofintensive investigation. Heath (1962) has suggested that
the dialkylnitrosamines are first dealkylated to yield monoalkylnitrosaminesand
these or carbonium ions or diazoalkanes formed from them alkylate vital sites in
the liver to produce the acute hepato-toxic lesion. Recently, Lijinsky et al. (1968)
in an elegant experiment utilizing deuterated dimethylnitrosamine, have shown
that for this compound at least alkylation ofDNA and RNA is affected by intact
carbonium ions presumably derived from monomethylnitrosamine. In the case
of DBN, Magee (1968) has reported the unexpected occurrence of 7-14C-methyl-
guanine instead of the butylated derivative in the nucleic acids of liver from rats
treated with labelled DBN. We have not found any information on the degrada-
tion of butyl compounds which would explain the production of this methylated
base.
It is not clear whether the sex difference in the induction of bladder tumours
observed in our experiments is due to the hormonal state ofthe bladder epithelium
or to metabolic differences in detoxication similar to those described in the rat
(Quinn et al., 1958). This latter explanation must be presumed to apply in the
case of 2-acetylaminofluorene which induces bladder tumours in male but not
female IF mice when administered by stomach tube, but when fed in the diet
induces tumours in a significantly greater number of females than males (Wood,
1969). It is of interest to note that for the population ofEngland and Wales the
incidence ofbladder cancer is three times higherin menthanin women (Case, 1959).
It is believed that DBN will prove to be a useful addition to the small number
of compounds that have been shown to induce bladder cancer in experimental
animals after oral administration, and its relative chemical simplicity should aid
studies into the nature of the proximal carcinogen. Its activity in the C57BL/6
mouse is relevant in terms of the low spontaneous tumour incidence in this strain
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and the large groups which may be economically kept in comparison with other
species. The potency of DBN as a bladder carcinogen is at least comparable to
those compounds tested in the mouse by Clayson et al. (1965), and is achieved
without signs of generalized toxicity, its use being compromised only by the high
level of oesophageal tumours.
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